학술논문

Phase I dose-escalation and expansion study of intratumoral CV8102, a RNA-based TLR- and RIG-1 agonist in patients with advanced solid tumors
Document Type
Article
Source
In: Annals of oncology : official journal of the European Society for Medical Oncology. (Annals of oncology : official journal of the European Society for Medical Oncology, 1 October 2018, 29:viii466)
Subject
Language
English
ISSN
15698041